CA2065403A1 - Transdermal delivery device having delayed onset - Google Patents

Transdermal delivery device having delayed onset

Info

Publication number
CA2065403A1
CA2065403A1 CA2065403A CA2065403A CA2065403A1 CA 2065403 A1 CA2065403 A1 CA 2065403A1 CA 2065403 A CA2065403 A CA 2065403A CA 2065403 A CA2065403 A CA 2065403A CA 2065403 A1 CA2065403 A1 CA 2065403A1
Authority
CA
Canada
Prior art keywords
delivery device
transdermal delivery
active compound
delivery
delayed onset
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2065403A
Other languages
French (fr)
Other versions
CA2065403C (en
Inventor
Gary W. Cleary
Jesus Miranda
Chia-Ming Chiang
Kenneth J. Colley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2065403A1 publication Critical patent/CA2065403A1/en
Application granted granted Critical
Publication of CA2065403C publication Critical patent/CA2065403C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A61F13/023—Adhesive bandages or dressings wound covering film layers without a fluid retention layer
    • A61F13/0243—Adhesive bandages or dressings wound covering film layers without a fluid retention layer characterised by the properties of the skin contacting layer, e.g. air-vapor permeability
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A61F13/0259—Adhesive bandages or dressings characterised by the release liner covering the skin adhering layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00902—Plasters containing means
    • A61F2013/00906—Plasters containing means for transcutaneous or transdermal drugs application

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A transdermal delivery device has a reservoir containing an active compound, which is kept separate from the delivery lay-ers of the device until administration. At the time of administration, the reservoir is laminated to the delivery layers, or is ruptured to place the active compound, vehicle, and/or permeation enhancers in contact with the delivery layers, which results in adminis-tration of the active compound to the skin after a delay period.
CA002065403A 1989-09-14 1990-09-13 Transdermal delivery device having delayed onset Expired - Fee Related CA2065403C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40747689A 1989-09-14 1989-09-14
US407,476 1989-09-14

Publications (2)

Publication Number Publication Date
CA2065403A1 true CA2065403A1 (en) 1991-03-15
CA2065403C CA2065403C (en) 1996-06-18

Family

ID=23612266

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002065403A Expired - Fee Related CA2065403C (en) 1989-09-14 1990-09-13 Transdermal delivery device having delayed onset

Country Status (6)

Country Link
EP (1) EP0491853A4 (en)
JP (1) JP2605183B2 (en)
AU (1) AU650851B2 (en)
CA (1) CA2065403C (en)
FI (1) FI921121A0 (en)
WO (1) WO1991003998A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI944321L (en) * 1992-11-05 1994-11-16 Becton Dickinson Co User-activated iontophoretic device and method for using the same
US5591767A (en) * 1993-01-25 1997-01-07 Pharmetrix Corporation Liquid reservoir transdermal patch for the administration of ketorolac
US5613958A (en) * 1993-05-12 1997-03-25 Pp Holdings Inc. Transdermal delivery systems for the modulated administration of drugs
EP0708627B1 (en) * 1993-07-09 2000-02-02 Cygnus, Inc. Method and device for providing nicotine replacement therapy transdermally/transbuccally
WO1996000072A1 (en) * 1994-06-23 1996-01-04 The Procter & Gamble Company Treatment of nicotine craving and/or smoking withdrawal symptoms with a transdermal or transmucosal composition containing nicotine and caffeine or xanthine
DE19736315A1 (en) * 1997-08-21 1999-02-25 Lohmann Therapie Syst Lts Active agent containing device, for dermal use
WO2005025549A2 (en) * 2003-09-10 2005-03-24 Noven Pharmaceuticals, Inc. Multi-layer transdermal drug delivery device
US8343538B2 (en) 2004-10-08 2013-01-01 Noven Pharmaceuticals, Inc. Compositions and methods for controlling the flux of a drug from a transdermal drug delivery systems
WO2006109325A1 (en) * 2005-04-11 2006-10-19 Roberto Vannucci Band-aid with a disinfectant container
CN101460156B (en) * 2006-05-08 2011-06-08 帝国制药株式会社 Transdermal Absorption Preparation of Antidementia Drugs
GB2438926A (en) * 2006-06-07 2007-12-12 Paul Marshall Transdermal patch
WO2008056139A2 (en) * 2006-11-08 2008-05-15 Regen Therapeutics Plc Transdermal therapy
GB2448855B (en) * 2007-05-04 2010-10-20 Mark Stephen Couchman Pressure activated transdermal medicament delivery system
FR2924349B1 (en) 2007-12-03 2010-01-01 Dbv Tech ALLERGEN DISENSIBILITY METHOD
GB201019761D0 (en) 2010-11-22 2011-01-05 Chowdhury Dewan F H Multilayered transdermal patch
KR102079270B1 (en) * 2017-04-28 2020-02-19 닛토덴코 가부시키가이샤 Transdermal absorption preparation precursor
CN109646806A (en) * 2018-12-17 2019-04-19 南京日光生物科技有限公司 A kind of backbone patch and preparation method thereof with far infrared heating layer

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3703890A (en) * 1970-08-10 1972-11-28 Milton A Saunders Jr Skin patch test device
US4117841A (en) * 1977-02-07 1978-10-03 Anthony Perrotta Medicated bandage pocket
US4286592A (en) * 1980-02-04 1981-09-01 Alza Corporation Therapeutic system for administering drugs to the skin
EP0249475A3 (en) * 1986-06-13 1989-10-11 Alza Corporation Delayed percutaneous delivery
ATE71287T1 (en) * 1986-06-13 1992-01-15 Alza Corp ACTIVATION OF A TRANSDERMAL DRUG DELIVERY SYSTEM BY MOISTURE.
JPS6425717A (en) * 1987-05-08 1989-01-27 Eastman Kodak Co Method and apparatus for preventing organic nitric acid ester resistance
US4839174A (en) * 1987-10-05 1989-06-13 Pharmetrix Corporation Novel transdermal nicotine patch
US4812305A (en) * 1987-11-09 1989-03-14 Vocal Rodolfo S Well medicine strip

Also Published As

Publication number Publication date
JP2605183B2 (en) 1997-04-30
AU650851B2 (en) 1994-07-07
FI921121L (en) 1992-03-16
EP0491853A1 (en) 1992-07-01
FI921121A7 (en) 1992-03-16
CA2065403C (en) 1996-06-18
JPH05500511A (en) 1993-02-04
AU6515390A (en) 1991-04-18
FI921121A0 (en) 1992-03-16
EP0491853A4 (en) 1992-11-04
WO1991003998A1 (en) 1991-04-04

Similar Documents

Publication Publication Date Title
CA2065403A1 (en) Transdermal delivery device having delayed onset
IE882960L (en) Osmotic dosage form for administering isradipine
CA2045290A1 (en) Plaster with a high content of softening ingredients
IE891070L (en) Laminated composite for transdermal administration of¹fentanyl
BE896578A (en) SUSTAINED DELIVERY DEVICE FOR A MEDICAMENT.
IE882080L (en) Transdermal therapeutic system
EP0316065A3 (en) Improved transdermal drug delivery device
EP0922453A3 (en) Percutaneous absorption type preparation containing tulobuterol
IE880834L (en) Active substance-containing plaster
EP0229022A3 (en) Novel pharmaceutical compositions comprising analgesic agents or caffeine
AU569431B2 (en) Pharmaceutical composition containing phenindamine
EP0357369A3 (en) The use of asymetric membranes in delivery devices
AU3290089A (en) Deprenyl for systemic transdermal administration
WO1995001167A3 (en) Incorporating poly-n-vinyl amide in a transdermal system
MY106242A (en) Pharmaceutical composition for the prevention of sexually transmitted diseases.
EP0114125A3 (en) Medication application systems
AU590921B2 (en) Delayed onset transdermal delivery device
IE900580L (en) Therapeutic system for the retarded and controlled¹transdermal or transmucous administration of active¹substances (ii)
CA2088778A1 (en) Transdermal contraceptive formulations, methods and devices
WO1987003480A3 (en) Medicament with anti-tumoral action containing hexadecylphosphocholine
AU7200387A (en) Device for self-administration of physiologically active substances, with prevention of overdosing
AU2501192A (en) Transdermal drug delivery device using an unfilled microporous membrane to achieve delayed onset
EP0235718A3 (en) Granule remaining in stomach
CA2190778A1 (en) Transmucosal delivery system
CA2276445A1 (en) Transdermal hormone-delivering therapeutic system

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed